Visium Asset Management’s Arbutus Biopharma ABUS Stock Holding History

Visium Asset Management’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-31,700	Closed	-$193K	–	580
2015 Q3	$193K	Buy	+31,700	New	+$281K	﹤0.01%	808
2015 Q2	–	Sell	-30,000	Closed	-$524K	–	1113
2015 Q1	$524K	Buy	+30,000	New	+$615K	0.01%	680

Other funds holding ABUS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Visium Asset Management's ABUS Position: Q4 2015 in Review

Visium Asset Management sold out of Arbutus Biopharma (ABUS) in Q4 2015, closing a stake of 31,700 shares — an estimated $193K sold.

Visium Asset Management first reported a position in ABUS in Q1 2015 and held it in 2 quarters. The position peaked at $524K in Q1 2015. 51 funds tracked by Wall St. Rank hold ABUS as of Q4 2015.

Visium Asset Management reported no remaining Arbutus Biopharma position as of Q4 2015 after selling out during the quarter.
Visium Asset Management sold 31,700 Arbutus Biopharma shares in Q4 2015, an estimated $193K.
Visium Asset Management first reported a position in Arbutus Biopharma in Q1 2015 and held it in 2 quarters.
Visium Asset Management's Arbutus Biopharma position peaked at $524K in Q1 2015.
51 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q4 2015.

Based on Visium Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.